All filters
Slidesets
Dolutegravir in contributing the 90:90:90 ambition | Tuna Lukiana MD, PhD
Presented at:
INTEREST 2016
Slidesets
New evidence on oral and topical PrEP for women: rings, gels, injectables | Nyaradzo Mgodi, MBChB, MMed
Presented at:
INTEREST 2016
Slidesets
Debate: Gilead: The Continent of Africa is Ready for HIV Pre-Exposure Prophylaxis (PreP) Implementation | Community Advocate | Stephen Watiti, MD
Presented at:
INTEREST 2016
Slidesets
(Abstract) Predictors of HIV-testing in South African adolescents: schools-based testing, pregnancy and sexual experience | C. Carty
Presented at:
INTEREST 2016
Slidesets
Trial, post-trial, & demonstration project results for Pre-exposure Prophylaxis (PrEP) | Elizabeth Irungu, MBChB, MPH
Presented at:
INTEREST 2016
Slidesets
(Abstract) EDCTP as a model for Europe-Africa partnership on HIV/AIDS research and capacity development: Examples from Cameroon | L.J. Pandya
Presented at:
INTEREST 2016
Slidesets
Update on HIV vaccine strategies and trials: Active and passive immunization strategies | Hannah Kibuuka, MD
Presented at:
INTEREST 2016
Slidesets
Prevention Tools: Implementation and Discovery | Cissy Kityo, MD
Presented at:
INTEREST 2016
Slidesets
Drug Use in sub-Saharan Africa: opportunities and challenges | Reychad Abdool, MD
Presented at:
INTEREST 2016
Slidesets
(Abstract) Finding the first 90% to achieve epidemic control | J. Masedza
Presented at:
INTEREST 2016
Slidesets
Men who have sex with men in sub-Saharan Africa | Iliassou Mfochive Njindam, MD, MPH
Presented at:
INTEREST 2016
Slidesets
(Abstract) Operational research studies among MSM in Cameroon: Linkage to treatment challenges | U. Tamoufe
Presented at:
INTEREST 2016
Slidesets
(Abstract) Pre-Clinical Evaluation of optimized Immunogens targeting the neutralizing epitopes in MPER of HIV envelope Glycoprotein
Presented at:
INTEREST 2016
Slidesets
(Abstract) Identification of Rare HIV-1 Group N and HTLV-3 Strains in Rural South Cameroon | N. Ndembi
Presented at:
INTEREST 2016
Meeting